XRAY

Barrington analyst Michael Petusky maintained a Buy rating on DENTSPLY SIRONA (XRAY - Research Report) today and set a price target of $40.00. The company's shares closed yesterday at $30.62.Petusky covers the Healthcare sector, focusing on stocks such as Anika Therapeutics, Henry Schein, and Lifecore Biomedical. According to TipRanks, Petusky has an average return of 7.3% and a 50.72% success rate on recommended stocks. The word on The Street in general, suggests a Moderate Buy analyst consensus rating for DENTSPLY SIRONA with a $34.67 average price target, implying a 13.23% upside from current levels.
https://www.tipranks.com/news/blurbs/barrington-remains-a-buy-on-dentsply-sirona-xray?utm_source=advfn.com&utm_medium=referral